Liminatus Pharma, Inc. Class A Common Stock (NASDAQ: LIMN) — Healthcare · Share Price, Chart & Market Data
About: Liminatus Pharma, Inc. operates as a pre-clinical stage biopharmaceutical company that develops novel cancer therapies. It is developing CD47, a high affinity humanized anti CD47 antibody that has the potential to translate into clinic for CD47 SIRPa blocking and restoring the anti-tumor function of innate immune cells without inducing hemagglutination or hemolysis. The company was founded in 2018 is based in LA Palma, California.
Sector: Healthcare
Industry: Biotechnology
Latest price: $0.20 (+0.25%)
LIMNLiminatus Pharma, Inc. Class A Common Stock
Loading watchlist status…
Trade LIMN now
Liminatus Pharma, Inc. Class A Common Stock share price
LIMN price activity
Last Price
Change (24hr)
USD (%)
Volume
Volume (4w avg)
Previous Close
N/A
Last Trade
Delayed
30 Apr, 4:25 am GMT+0
LIMN price performance
2.354%
5D
15.48%
1M
-68.097%
YTD
-96.821%
1Y
LIMN price fundamentals
N/A
Shares Issued
N/A
Dividends Per Share (DPS)
N/A
Earnings Per Share (EPS)
N/A
P/E Ratio
Price market cap
Market cap
N/A
NASDAQ rank
N/A
Sector Rank
N/A
Delayed
30 Apr, 4:25 am GMT+0
LIMN details
LIMN Market Signals